Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02087-y
|
Genetic predisposition in Tachycardia-induced cardiomyopathy
|
N. Dybkova1, C. Brand1, N. Hartmann1, S. Rebs1, P. Tirilomis1, J. Beier1, A. Zibat1, D. Vollmann2, G. Hasenfuß1, B. Wollnik3, S. T. Sossalla4, K. Streckfuß-Bömeke5
|
1Herzzentrum, Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Göttingen; 2Kardiologie, Herz- und Gefäßzentrum am Krankenhaus Neu-Bethlehem, Göttingen; 3Humangenetik, Institute for Human Genetics, University Medical Center Göttingen, Göttingen; 4Klinik und Poliklinik für Innere Med. II, Kardiologie, Universitätsklinikum Regensburg, Regensburg; 5Institut für Pharmakologie und Toxikologie, Universitätsklinikum Würzburg, Würzburg;
|
Aim/Hypothesis: Tachycardia-induced cardiomyopathy (TCM) is characterized by left ventricular systolic dysfunction which is caused by rapid ventricular rate. A major feature of TCM is its reversibility once tachycardia is eliminated. The pathophysiological mechanism underlying TCM remain unclear. In humans, manifestation of TCM can have variable effects on systolic function in different individuals. We hypothesized that a genetic predisposition plays a role in the development of TCM.
Methods and Results: To investigate genetic predisposition and mechanisms of early tachycardia-induced electrophysiological remodeling, we generated human induced pluripotent stem cells (iPSCs) from three patients with precisely diagnosed TCM (MRI, coronary angiography, myocardial biopsy and full recovery of initially largely depressed LV function upon rhythm therapy) due to tachyarrhythmia and compared them to two patients who did not develop TCM (control) despite incessant and for many months untreated tachyarrhythmia. Whole exome sequencing analysis showed mutations in cardiomyopathy-associated genes and/or missense or truncating mutations in the cardiac ion channel KCNQ1 in two of three TCM patients. To confirm the relevance of these mutations, we generated 2-month-old iPSC-cardiomyocytes (iPSC-CM). Using confocal microscopy we observed a significant reduction of sarcomeric regulation already under basal conditions in TCM patients with sarcomeric mutations. The effect of persistent tachycardia on cardiomyocytes was evaluated by chronical culture field pacing of the iPSC-CM either by tachycardia (Tachy, 120 bpm) or normal frequency (SR, 60 bpm) for 24 h or 7 days. Sarcomeric regulation was significantly decreased after 7 days of Tachy stimulation compared to SR in all patients. Whole-cell current clamp showed a potent prolongation of action potential duration (APD80) in all TCM patients with KCNQ1 mutations after 24 h Tachy stimulation compared to normal frequency. The effect of tachycardia on the iPSC-CM Ca2+-handling was studied via Fura-2 AM epifluorescence measurements. Interestingly, Ca2+ -transient amplitude was already significantly reduced in TCM patients after 24 h of SR stimulation compared to control iPSC-CM patient lines under the same conditions. Therefore, tachycardia stimulation had no additional effect in TCM patients, but decreases Ca2+-transients in control patients compared to SR. We further elucidated the underlying mechanism by showing that markers of oxidative stress (H2O2) are potently increased after 7d of field stimulation (SR and Tachy in all patients and controls) with a significantly higher amount of H2O2 after Tachy versus SR in one TCM patient.
Conclusion: This study provides the first indirect hint that mutations functionally alter cellular electrophysiology and seem to play a relevant role for the development of TCM. Therefore, investigation of the underlying mechanisms and involved key targets may define new translational understanding of TCM.
|
https://dgk.org/kongress_programme/ht2022/aBS673.html
|